Daily Care News for August 10, 2016
advertisement
- Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes. See also Combination Therapy for Type 1 Diabetes Improves Blood Glucose Control.
- Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
- Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: the ADJUNCT TWO Randomized Trial.
- Adjunctive Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Type 1 Diabetes Mellitus.
- Evaluating Substance Use and Insulin Misuse in Adolescents With Type 1 Diabetes.
- Stress and Coping Predicts Adjustment and Glycemic Control in Adolescents with Type 1 Diabetes.
- Adolescent Disclosure to Parents and Daily Management of Type 1 Diabetes.
- Longitudinal Patterns of Glycemic Control and Blood Pressure in Pregnant Women with Type 1 Diabetes Mellitus: Phenotypes from Functional Data Analysis.
- Timeliness of referral of children with new onset type 1 diabetes.
- Severity of clinical presentation in youth with type 1 diabetes is associated with differences in brain structure.
- Prepregnancy Weight in Women with Type I Diabetes Mellitus: Effect on Pregnancy Outcomes.
- Does Reducing Basal Insulin During Ramadan Fasting by Children and Adolescents with Type 1 Diabetes Decrease the Risk of Symptomatic Hypoglycemia?
